Xuehao Wang

13.0k total citations · 7 hit papers
239 papers, 9.3k citations indexed

About

Xuehao Wang is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Xuehao Wang has authored 239 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Molecular Biology, 71 papers in Immunology and 67 papers in Surgery. Recurrent topics in Xuehao Wang's work include Organ Transplantation Techniques and Outcomes (47 papers), Liver Disease and Transplantation (31 papers) and Immune Cell Function and Interaction (26 papers). Xuehao Wang is often cited by papers focused on Organ Transplantation Techniques and Outcomes (47 papers), Liver Disease and Transplantation (31 papers) and Immune Cell Function and Interaction (26 papers). Xuehao Wang collaborates with scholars based in China, United States and United Kingdom. Xuehao Wang's co-authors include Runqiu Jiang, Dawei Rong, Beicheng Sun, Weiwei Tang, Liyong Pu, Xiongxiong Pan, Betty Zhang, Jindao Wu, Yongxiang Xia and Jianhua Rao and has published in prestigious journals such as Advanced Materials, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Xuehao Wang

234 papers receiving 9.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects

2020 752 citations Weiwei Tang, Ziyi Chen et al. Signal Transduction and Targeted Therapy profile →
M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma

2020 338 citations Xuehao Wang et al. profile →
Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities

2019 319 citations Lu Chen, Dawei Rong et al. profile →
HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation

2021 281 citations Liren Zhang, Runqiu Jiang et al. Signal Transduction and Targeted Therapy profile →
Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing

2022 194 citations Xiaopei Hao, Zhiying Zheng et al. profile →
FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2

2022 152 citations Hongbing Shen, Xuehao Wang et al. profile →
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives

2024 84 citations Dong-Min Shi, Jinhua Song et al. Signal Transduction and Targeted Therapy profile →

Peers

Countries citing papers authored by Xuehao Wang

Since Specialization

Citations

This map shows the geographic impact of Xuehao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuehao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuehao Wang more than expected).

Fields of papers citing papers by Xuehao Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuehao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuehao Wang. The network helps show where Xuehao Wang may publish in the future.

Co-authorship network of co-authors of Xuehao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuehao Wang. A scholar is included among the top collaborators of Xuehao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuehao Wang. Xuehao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cuproptosis-associated genes (CAGs) contribute to the prognosis prediction and potential therapeutic targets in hepatocellular carcinoma 2024 ·Cellular Signalling ·Xiaoli Shi, Dong-Min Shi, (unknown), Yuxiao Wu, Wenwei Chen, Yue Yu, Xuehao Wang	3
2	Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives breakdown → 2024 ·Signal Transduction and Targeted Therapy ·(unknown), (unknown), (unknown), Dong-Min Shi, (unknown), (unknown), (unknown), Jinhua Song, Weiwei Tang, Xuehao Wang	84
3	MAL2 reprograms lipid metabolism in intrahepatic cholangiocarcinoma via EGFR/SREBP-1 pathway based on single-cell RNA sequencing 2024 ·Cell Death and Disease ·(unknown), (unknown), (unknown), (unknown), Shipeng Dai, Liu L, Yuliang Wang, (unknown), Xuehao Wang, Yun Gao, Weiwei Tang, Yongxiang Xia	10
4	GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway 2023 ·Journal for ImmunoTherapy of Cancer ·Dawei Rong, Yuliang Wang, Li Liu, (unknown), Tian Huang, Hanyuan Liu, Xiaopei Hao, Guangshun Sun, Guoqiang Sun, Zhiying Zheng, (unknown), Yongxiang Xia, (unknown), Weiwei Tang, Xuehao Wang	17
5	Single-cell RNA-sequencing atlas reveals an FABP1-dependent immunosuppressive environment in hepatocellular carcinoma 2023 ·Journal for ImmunoTherapy of Cancer ·Weiwei Tang, Guangshun Sun, Gu‐Wei Ji, Tingting Feng, Qian Zhang, (unknown), (unknown), (unknown), Chuan Liu, (unknown), (unknown), Li Liu, Yongxiang Xia, Xuehao Wang	29
6	The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers 2022 ·Nature Communications ·(unknown), Zijian Ma, Changxian Li, (unknown), Wangjie Jiang, Jiang Chang, Sheng Han, (unknown), (unknown), Yirui Wang, Hongwei Wang, Chenyu Jiao, Dong Wang, Xiaofeng Wu, Hongbing Shen, Xuehao Wang, Zhibin Hu, Xiangcheng Li	38
7	c-Myc-driven glycolysis polarizes functional regulatory B cells that trigger pathogenic inflammatory responses 2022 ·Signal Transduction and Targeted Therapy ·Xuyan Wang, Wei Yuan, Bo Hu, Yuan Liao, Xiaodong Wang, (unknown), (unknown), (unknown), Zhengyu Liu, (unknown), Xiaodan Chen, Dong‐Ping Chen, Dong‐Ming Kuang, Xuehao Wang, Yun Chen	41
8	PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells 2022 ·Nature Communications ·Qing Li, Liren Zhang, Wenhua You, Jiali Xu, Jingjing Dai, (unknown), Ruizhi Zhang, (unknown), (unknown), Wei Huang, (unknown), Yu Zhang, (unknown), Xiaofeng Qian, Liyong Pu, Jing Xu, Yongxiang Xia, (unknown), Jinhai Tang, Xuehao Wang	61
9	CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ 2022 ·Journal of Experimental & Clinical Cancer Research ·Xiaopei Hao, Yao Zhang, Xiaoli Shi, Hanyuan Liu, Zhiying Zheng, Guoyong Han, Dawei Rong, Chuanyong Zhang, Weiwei Tang, Xuehao Wang	57
10	Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy 2022 ·Journal for ImmunoTherapy of Cancer ·Guangshun Sun, Hanyuan Liu, Jie Zhao, Jinyu Zhang, (unknown), Guoqiang Sun, (unknown), Zihao Zhang, (unknown), Dawei Rong, Xiangyi Kong, Qinghua Ji, Li Liu, Xuehao Wang, Weiwei Tang, Yongxiang Xia	29
11	SET/PP2A signaling regulates macrophage positioning in hypoxic tumor regions by amplifying chemotactic responses 2022 ·Experimental & Molecular Medicine ·Shaolong Zhang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ziyi Chen, Xuehao Wang, Changying Guo	3
12	m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression 2021 ·Molecular Therapy — Nucleic Acids ·Dawei Rong, Fan Wu, Lu Chen, Guangshun Sun, Xiaoli Shi, Xiaoyuan Chen, (unknown), Weizhe Zhong, Xiaopei Hao, Jinren Zhou, Yongxiang Xia, Weiwei Tang, Xuehao Wang	77
13	Isoform- and Cell Type–Specific Roles of Glycogen Synthase Kinase 3 N-Terminal Serine Phosphorylation in Liver Ischemia Reperfusion Injury 2020 ·The Journal of Immunology ·(unknown), Haoming Zhou, Jing Zhang, Dan Jin, Tianfei Lu, Ronald W. Busuttil, Jerzy W. Kupiec‐Weglinski, Xuehao Wang, Yuan Zhai	4
14	The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects breakdown → 2020 ·Signal Transduction and Targeted Therapy ·Weiwei Tang, Ziyi Chen, Wenling Zhang, Ye Cheng, Betty Zhang, Fan Wu, Qian Wang, Shouju Wang, Dawei Rong, Florian P. Reiter, Enrico N. De Toni, Xuehao Wang	752
15	Blockade of miR-142-3p promotes anti-apoptotic and suppressive function by inducing KDM6A-mediated H3K27me3 demethylation in induced regulatory T cells 2019 ·Cell Death and Disease ·Ji Gao, Jian Gu, Xiongxiong Pan, Xiaojie Gan, (unknown), (unknown), Yongxiang Xia, Ling Lu, Xuehao Wang	28
16	Anti-IL-22 Antibody Attenuates Acute Graft-versus-Host Disease via Increasing Foxp3⁺T Cell through Modulation of CD11b⁺Cell Function 2018 ·Journal of Immunology Research ·Jianbo Wu, Jian Gu, Shun Zhou, Hao Lu, Yunjie Lu, Ling Lu, Xuehao Wang	6
17	Increased Risk of Cancer in relation to Gout: A Review of Three Prospective Cohort Studies with 50,358 Subjects 2015 ·Mediators of Inflammation ·Weijie Wang, Donghua Xu, Bin Wang, Shushan Yan, Xiaochen Wang, Yin Yin, Xuehao Wang, (unknown), Xiaoyang Sun	44
18	Interleukin-17A level in patients with liver cirrhosis and its clinical significances 2012 ·Xuehao Wang	1
19	miR-22 Promotes HBV-Related Hepatocellular Carcinoma Development in Males 2011 ·Clinical Cancer Research ·Runqiu Jiang, Lei Deng, Liang Zhao, Xiangcheng Li, Feng Zhang, Yongxiang Xia, Yun Gao, Xuehao Wang, Beicheng Sun	64
20	[Pigment epithelium-derived factor gene therapy inhibits the growth of transplanted human hepatocellular carcinoma in nude mice]. 2009 ·PubMed ·Yun Gao, Wei Zhang, Liang Zhao, Xuehao Wang	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact